Inactive Instrument

Press Releases Actavis Inc Nyse

Equities

US9426831031

End-of-day quote Nyse Other stock markets
- ^USD	-

Mar. 05	Allergan Aesthetics Announces the U.S. FDA Approval of JUVEDERM VOLUMA XC for Injection in the Temple Region to Improve Moderate to Severe Temple Hollowing in Adults over the Age of 21	CI
2023	Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of Onabotulinumtoxina for the Treatment of Platysma Prominence	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	Apr. 01	AQ
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	22-04-20	AQ
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision	22-04-06	AQ
AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting	22-03-22	AQ
Allergan - VUITY 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry near Vision, is Now Available	21-12-10	AQ
Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the Treatment of Presbyopia	21-10-27	AQ
Hagens Berman: Law Firm Investigating Permanent Injuries and Disfigurement from Botched CoolSculpting Procedures	21-10-05	BU
AbbVie : Allergan - FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity	21-07-30	AQ
AbbVie : Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting	21-07-21	AQ
Stamp Duty Battle: Abbvie Wins Appeal Against €587m Irish Stamp Duty	21-04-16	AQ
AbbVie : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference	21-01-18	AQ
Allergan : an AbbVie company to Share New Data at American Academy of Ophthalmology 2020 Virtual	20-11-09	AQ
AbbVie : Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia	20-10-29	AQ
Allergan : an AbbVie Company, and Von Miller Encourage People with Glaucoma to Design Their Disease Management Plan	20-10-09	AQ
AbbVie : Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol	20-06-29	AQ
TherapeuticsMD : Announces Appointment of James C. D'Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer	20-06-02	AQ
AbbVie : Completes Transformative Acquisition of Allergan	20-05-11	AQ
ALLERGAN PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	20-05-08	AQ
Allergan : AbbVie Inc. Completes Acquisition of Allergan plc	20-05-08	PR
Allergan : Foundation Doubles its COVID-19 Response Donations to $4.0 Million	20-05-07	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Actavis Inc Nyse

Equities

US9426831031

Press Releases

Filters